Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) carry list prices between $900 and $1,400 per month without insurance. With manufacturer coupons or commercial insurance, some patients pay significantly less — but coverage for weight management indications is still inconsistent and frequently denied.

Compounded semaglutide and tirzepatide, produced by licensed 503A and 503B compounding pharmacies, can run as low as $150 to $400 per month depending on dosage and the telehealth platform prescribing it. That is a price difference large enough to make the compounded route the default starting point for most cash-pay patients — provided they are working with a physician-supervised program and a reputable pharmacy.

The total monthly cost of a GLP-1 program depends on four main factors: the peptide itself (brand vs compounded), the dosage you are currently on, the telehealth platform subscription or consultation fee, and any required lab work. Some platforms bundle all of these into a flat monthly price. Others price the medication separately from the clinical oversight fees.

Platforms that show the lowest advertised price often use a starter dose that many patients will need to titrate beyond, meaning the real monthly cost at therapeutic dosage can be 30 to 80 percent higher than the entry number. Always check what the cost looks like at the maintenance dose, not just the first month.

GLP-1 pricing changes frequently. Compounding pharmacy availability has shifted significantly as the FDA has updated its stance on shortage designations for semaglutide and tirzepatide. Platforms that were competitive six months ago may have changed pricing, and new entrants frequently undercut established players to build market share.

The most reliable way to track current GLP-1 pricing is through a dedicated resource that monitors deals and platform pricing in real time. CheapGLP1Deals.com aggregates current compounded GLP-1 offers, coupon codes, and platform promotions so you can compare what is actually available right now rather than relying on pricing that may already be stale.

The cheapest GLP-1 program is not always the best value. The key variables to check beyond price include: whether the compounding pharmacy is accredited (503A or 503B licensed), whether a physician reviews your intake form and monitors your progress, what the titration protocol looks like, and whether the platform offers support if you experience side effects.

GLP-1 side effects — particularly nausea, vomiting, and GI discomfort — are common during dose escalation. A program with active clinical oversight will help you manage the titration timeline in a way that improves tolerability and long-term adherence. A program that sends medication with minimal clinical contact is a cost saving that may come at the expense of outcomes.

Beyond weight management, GLP-1 agonists are showing promise in cardiovascular risk reduction, cognitive health, and metabolic optimization that is relevant to the longevity space. The CVOT data for semaglutide has attracted significant attention from longevity-focused physicians who are incorporating GLP-1 protocols into broader optimization programs alongside hormone therapy, NAD+ support, and lifestyle interventions.

If you are already working with a longevity or telehealth provider on hormone optimization or peptide protocols, it is worth asking whether GLP-1 therapy fits your goals — and whether your current platform can prescribe it or if a specialized resource like CheapGLP1Deals.com would help you find the most cost-effective access point for that specific medication.